Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSA Pharma

1.48
-0.1000-6.33%
Post-market: 1.500.0200+1.35%19:47 EDT
Volume:311.58K
Turnover:471.96K
Market Cap:65.70M
PE:-2.11
High:1.59
Open:1.57
Low:1.43
Close:1.58
Loading ...
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 29, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Oct 27, 2023

Major Issues Report

Form 8-K - Current report
Oct 23, 2023

Major Issues Report

Form 8-K - Current report
Oct 07, 2023

Correspondence

Form CORRESP - Correspondence
Oct 06, 2023

Correspondence

Form CORRESP - Correspondence
Oct 04, 2023

Correspondence

Form CORRESP - Correspondence